<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

Novel crispr–cas systems: An updated review of the current achievements, applications, and future research perspectives

dc.contributor.authorNidhi, S.
dc.contributor.authorAnand, U.
dc.contributor.authorOlekšák, Patrik
dc.contributor.authorTripathi, P.
dc.contributor.authorLal, J.A.
dc.contributor.authorThomas, G.
dc.contributor.authorKuča, Kamil
dc.contributor.authorTripathi, V.
dc.date.accessioned2026-07-21T06:18:13Z
dc.date.available2026-07-21T06:18:13Z
dc.date.issued2021
dc.description.abstractAccording to Darwin’s theory, endless evolution leads to a revolution. One such example is the Clustered Regularly Interspaced Palindromic Repeats (CRISPR)–Cas system, an adaptive immunity system in most archaea and many bacteria. Gene editing technology possesses a crucial potential to dramatically impact miscellaneous areas of life, and CRISPR–Cas represents the most suitable strategy. The system has ignited a revolution in the field of genetic engineering. The ease, precision, affordability of this system is akin to a Midas touch for researchers editing genomes. Undoubtedly, the applications of this system are endless. The CRISPR–Cas system is extensively employed in the treatment of infectious and genetic diseases, in metabolic disorders, in curing cancer, in developing sustainable methods for fuel production and chemicals, in improving the quality and quantity of food crops, and thus in catering to global food demands. Future applications of CRISPR– Cas will provide benefits for everyone and will save countless lives. The technology is evolving rapidly; therefore, an overview of continuous improvement is important. In this review, we aim to elucidate the current state of the CRISPR–Cas revolution in a tailor‐made format from its discovery to exciting breakthroughs at the application level and further upcoming trends related to opportunities and challenges including ethical concerns. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.eng
dc.formatp. &quot;Article number 3327&quot;
dc.identifier.doi10.3390/ijms22073327
dc.identifier.issn1422-0067
dc.identifier.obd43877573
dc.identifier.scopus2-s2.0-85102945416
dc.identifier.urihttp://hdl.handle.net/20.500.12603/2738
dc.identifier.wos000638625400001
dc.language.isoeng
dc.peerreviewedyes
dc.publicationstatuspostprint
dc.publisherMDPI-Molecular diversity preservation international
dc.relation.ispartofInternational journal of molecular sciences, volume 22, issue: 7eng
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/22/7/3327
dc.rights.accessOpen Access
dc.rights.licenseCC BY
dc.source.urlhttps://www.mdpi.com/1422-0067/22/7/3327
dc.subjectAgricultural productioneng
dc.subjectCRISPR/Cas9eng
dc.subjectGenome editingeng
dc.subjectIndustrial applicationseng
dc.subjectLivestockeng
dc.subjectTherapeuticseng
dc.titleNovel crispr–cas systems: An updated review of the current achievements, applications, and future research perspectiveseng
dc.typearticle

Soubory

Původní svazek

Nyní se zobrazuje 1 - 1 z 1
Načítá se...
Náhled
Název:
ijms-22-03327-v3.pdf
Velikost:
7,83 MB
Formát:
Adobe Portable Document Format